本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Denali Therapeutics Inc.

21.09
-0.3100-1.45%
盤後21.090.00000.00%19:59 EDT
成交量:123.95萬
成交額:2,626.64萬
市值:33.71億
市盈率:-7.44
高:21.79
開:21.65
低:21.06
收:21.40
52周最高:27.30
52周最低:12.58
股本:1.60億
流通股本:1.51億
量比:0.86
換手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-2.8353
每股收益(LYR):-2.9700
淨資產收益率:-54.93%
總資產收益率:-29.15%
市淨率:4.04
市盈率(LYR):-7.10

資料載入中...

2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities